|
|
1.
|
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors:
Citation: - Lancet. 385(9986):2477-84, 2015 Jun 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Akin J, Anderson WN, Babaliaros V, Bavaria J, Blackstone EH, Brown DL, Davidson MJ, Douglas PS, Fontana GP, Hahn RT, Herrmann HC, Kapadia S, Kodali SK, Leon MB, Mack MJ, Makkar RR, Miller DC, Moses JW, PARTNER 1 trial investigators, Pichard A, Smith CR, Svensson LG, Thourani VH, Tuzcu EM, Webb JG, Williams M
|
|
|
2.
|
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors:
Citation: - Lancet. 385(9986):2485-91, 2015 Jun 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Akin JJ, Anderson WN, Babaliaros VC, Davidson MJ, Douglas PS, Fontana GP, Herrmann HC, Kapadia SR, Kodali S, Leon MB, Mack MJ, Makkar RR, Miller DC, PARTNER trial investigators, Pichard AD, Smith CR, Svensson LG, Szeto WY, Thourani VH, Tuzcu EM, Webb JG, Williams MR
|
